6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer

類似資料

• 6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease
  著者:: Buckley, Benjamin J., 等
  出版事項: (2019)
• The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets
  著者:: Buckley, Benjamin J., 等
  出版事項: (2019)
• Fluorescence properties of the Na(+)/H(+) exchanger inhibitor HMA (5-(N,N-hexamethylene) amiloride) are modulated by intracellular Ph
  著者:: Giansanti, V., 等
  出版事項: (2012)
• Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1
  著者:: Lin, Zhonghui, 等
  出版事項: (2011)
• 2-Amidino Analogs of Glycine-Amiloride Conjugates: Inhibitors of Urokinase-type Plasminogen Activator
  著者:: Massey, Archna P., 等
  出版事項: (2012)